US 9642898
Use of serine protease inhibitors in the treatment of neutropenia
granted A61KA61K35/15A61K35/28
Quick answer
US patent 9642898 (Use of serine protease inhibitors in the treatment of neutropenia) held by MED DISCOVERY S.A. expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- MED DISCOVERY S.A.
- Grant date
- Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K35/15, A61K35/28, A61K38/1709, A61K38/57